QualityStocksNewsBreaks Archives - Page 799 of 1497

TuesdayMar 30, 2021 1:45 pm

QualityStocksNewsBreaks – PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) Announces New CEO Appointment

PowerBand Solutions’ (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA), an innovative automotive fintech leader providing digital and virtual platform solutions to buy, sell, trade, lease, or finance vehicles to consumers, dealers, and OEMs, has announced the appointment of Jon Lamb to the position of CEO at MUSA Holdings ("MUSA"). Lamb has been serving as president of DRIVRZ(TM) and is well known for his expertise in technologies, business strategy, product development, marketplaces and capitalization. He has founded several companies and served in executive leadership positions in various successful business entities; he also has a special expertise in the automotive and marketing sectors. A…

TuesdayMar 30, 2021 12:35 pm

QualityStocksNewsBreaks – Mohawk Group Holdings Inc. (NASDAQ: MWK) CEO Featured on DealMaker Show

Mohawk Group (NASDAQ: MWK) co-founder and CEO Yaniv Sarig was featured on a recent episode of The DealMaker show. The Dealmaker Show is a fast-paced, high-energy forum hosted by best-selling author Oren Klaff. During the interview, Sarig talked about the Mohawk Group business model and as well as discussing the company’s proprietary AIMEE(R) (“AIMEE”) platform, which is designed to automate the development and launch of best-selling consumer products. Sarig also shared how the company is working to leverage and strengthen its foothold in the ecommerce space. “What we’ve done with Mohawk is we’ve built a hybrid of a technology company…

TuesdayMar 30, 2021 12:24 pm

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Preclinical Data Highlighting Potential for TUSC2 Immunogene Therapy to Be Featured at AACR 21

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes, today announced that preclinical data of its TUSC2 immunogene therapy (REQORSA(TM)) in combination with chemotherapy and immunotherapies, as well as in combination with targeted therapies to overcome resistance to osimertinib, for the treatment of non-small cell lung cancer (“NSCLC”), will be featured in two presentations at the upcoming annual meeting of the American Association for Cancer Research (“AACR 21”). The event is slated to take place virtually from April 9-14, 2021. “We look forward to the presentation of these data that…

TuesdayMar 30, 2021 12:03 pm

QualityStocksNewsBreaks – Asia Broadband Inc. (AABB) Increases Upcoming Stock Dividend

Asia Broadband (OTC: AABB), a resource company focused on the production, supply and sale of precious and base metals, today announced that its management and board of directors have approved an increase in the upcoming stock dividend. According to the update, the restricted common share dividend will be distributed on the basis of one dividend share for every 45 shares owned to AABB shareholders of record on May 3, 2021. In response to shareholder requests and interest, the company increased the dividend by 10% and extended the shareholders of record date. The majority of shareholders will receive the dividend shares…

TuesdayMar 30, 2021 11:38 am

QualityStocksNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Unveils New MyoCorrect Orofacial Myofunctional Therapy Service

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing including obstructive sleep apnea (“OSA”), has announced a new service called MyoCorrect. The exclusive training provides therapists with access to orofacial myofunctional therapy (“OMT”) via telemedicine technology using the company’s Vivos System. Vivos anticipates this new service will provide increased revenue through With this new training, Vivos expects to see additional revenue through increased cases and fees. The company expects its MyoCorrect service will become an effective treatment of OSA, thereby giving Vivos an additional competitive advantage in the OSA treatment…

TuesdayMar 30, 2021 11:14 am

QualityStocksNewsBreaks – Uranium Energy Corp. (NYSE American: UEC) Featured in Bell2Bell Podcast

Uranium Energy (NYSE American: UEC), a Corpus Christi, Texas-based uranium mining and exploration company, was featured in The Bell2Bell Podcast, a part of InvestorBrandNetwork’s (“IBN”) sustained effort to provide specialized content distribution via widespread syndication channels. Uranium Energy’s CEO and President, Amir Adnani, joined the latest episode to discuss the company’s recent news and milestones, which include strengthening of its balance sheet that totals close to $95 million in cash and equity holdings, including approximately $61 million in cash. Adnani also discussed the company’s establishment of a physical uranium holding initiative. “This has really both resonated with the market and,…

TuesdayMar 30, 2021 10:55 am

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Leverages Multi-Omic Approach to New Drug Discovery

Predictive Oncology (NASDAQ: POAI) is a knowledge-driven company focused on applying data and artificial intelligence (“AI”) to cancer personalized medicine and drug discovery. While the pharmaceutical industry has historically invested heavily in genomics and big data, hoping to better understand individual patient’s genomes and deliver targeted therapeutics, the use of genomics alone has proven disappointing. Predictive Oncology is confident that a multi-omic approach offers a much greater ability for success. The company is a leader in this area where few comprehensive, multi-omic datasets exist, especially in cancer, and such data is difficult to quickly access, as well as costly and…

TuesdayMar 30, 2021 10:32 am

QualityStocksNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Featured in Latest Episode of Bell2Bell Podcast

Green Hygienics Holdings (OTCQB: GRYN) was featured in The Bell2Bell Podcast, a part of InvestorBrandNetwork’s (“IBN”) sustained effort to provide specialized content distribution via widespread syndication channels. GRYN’s CEO, Ron Loudoun, joined the latest episode, where he highlighted last year’s milestones in establishing GRYN at the company’s 824-acre farm with 400,000 square feet of greenhouse. “We cultivated 120 acres last year and it turned out beautifully. We’ve proven out our ability to grow premium product there,” Loudoun said, discussing the property’s idyllic environment for the hemp plant with nutrient-rich soil, altitude that enables night-time cooling for better growth and an…

TuesdayMar 30, 2021 10:32 am

QualityStocksNewsBreaks – Rritual Superfoods Inc. (CSE: RSF) Full Product Line to Launch in Rite Aid Retail Locations, on e-Commerce Site

Rritual Superfoods (CSE: RSF, RSF.WT), a functional superfood company that creates plant-based elixirs that support immunity, focus and relaxation, has announced that its products will be available in Rite Aid retail stores located across the United States; beginning in Q2 and Q3 2021, an estimated 1,000 Rite Aid locations, along with the Rite Aid e-commerce site, will offer Rritual superfoods. Rritual has a strategic development plan targeting major retailers in order to gain market share and category-defining leadership, and the distribution agreement with Rite Aid, the third largest drugstore chain in the country, aligns with this focus. Rite Aid will…

TuesdayMar 30, 2021 9:58 am

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Appoints New Management Positions, Focused on Development and Clinical Operations

Cybin (NEO: CYBN) (OTCQB: CLXPF) announced changes in senior management positions. Cybin US Holdings Inc.’s new chief clinical officer will be Alexander Belser, PhD and its new chief operating officer will be Aaron Bartlone. In addition, co-founder and former COO Paul Glavine has been named chief growth officer and co-founder of Cybin Inc., while former SVP of business development John Kanakis will become chief business officer. The changes are effective immediately. An accomplished biopharmaceutical executive with a proven track record across numerous therapeutic and functional areas, Bartlone has extensive experience with quality assurance, regulatory affairs, product development, compliance and commercial…

Site Search

Company Search

Category: QualityStocksNewsBreaks